MedChemNet and Infectious Diseases Hub recently attended the first two days of the 19th RSC / SCI Medicinal Chemistry Symposium. Here, you can catch up on the session delving into drug discovery for the neglected tropical diseases.
Missed out on attending the British Society for Parasitology’s Autumn Symposium? Read our report of the event here, including talks from Roy Anderson and David Molyneux.
Julie Kaiser discusses the findings and implications of a recent study published in PNAS modeling the sequence of events that increases the risk of colonization and infection with multidrug-resistant (MDR) bacteria.
To mark World Rabies Day take a look at our infographic highlighting the current rabies burden and summarizing the strategy aiming to ensure there are zero cases of dog-mediated rabies by 2030.
Read our report covering the Knowledge Transfer Network’s vaccine development and manufacture event, focusing on the future innovation landscape for the UK and covering topics from new technologies to scale-down models for producing cheaper vaccines.
Editor, Martha Powell, discusses the issues around the current guidance for treating HAT and gives an overview of the current clinical pipeline being spearheaded by the Drugs for Neglected Diseases initiative.
In this column author, Julie Kaiser, explores two recent studies that have highlighted how prior antibiotic exposure can influence the later occurrence of resistance to other antibiotics in Pseudomonas aeruginosa.
Take a look at our infographic to find out more about the burden of some common fungal infections and assess why the facts and figures are so uncertain.
Several recent papers have investigated how polymicrobial interactions in the cystic fibrosis (CF) lung influence antimicrobial efficacy, demonstrating that microbial metabolites produced by one pathogen can alter the antimicrobial killing of another pathogen.